A number of studies report that circulating MPO levels independently predict adverse cardiovascular events in patients with chest pain, acute coronary syndrome, or AMI (Baldus et al., 2003; Brennan et al., 2003; Khan et al., 2007; Mocatta et al., 2007; Morrow et al., 2008). This evidence concerns the gene MPO and acute coronary syndrome.